Repositioning Candidates

Repositioning candidates for NAFLD are derived from DrugBank which fall into three categories: therapeutic strategy-associated, target-associated, and indication-associated candidates. For each candidate, detailed properties are extracted from DrugBank, and related strategies, target and NAFLD-associated disease in NAFLDkb are presented with knowledge graphs.

stats1
stats2
stats3

Search for:

     Type-1 angiotensin II receptor
12 records.
Candidate ID Source ID Source Type Compound Type Candidate Name Inclusion Criteria
R0064 DB00177 approved; investigational small molecule Valsartan Therapeutic strategy associated Details
R0283 DB00796 approved small molecule Candesartan cilexetil Target associated Details
R0320 DB00876 approved small molecule Eprosartan Target associated Details
R0377 DB01029 approved; investigational small molecule Irbesartan Target associated Details
R0497 DB01342 experimental small molecule Forasartan Target associated Details
R0498 DB01347 experimental small molecule Saprisartan Target associated Details
R0500 DB01349 experimental small molecule Tasosartan Target associated Details
R0858 DB05739 investigational biotech CYT006-AngQb Therapeutic strategy associated Details
R1161 DB08822 approved; investigational small molecule Azilsartan medoxomil Target associated Details
R1280 DB09279 investigational small molecule Fimasartan Therapeutic strategy associated Details
R1413 DB11842 approved; investigational small molecule Angiotensin II Target associated Details
R1502 DB13919 experimental small molecule Candesartan Target associated Details